Subarachnoid Haemorrhage (SAH)
7
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
ALI & Pulmonary HA Deposition After SAH
Effect of Abdominal Massage on Bowel Movements in Patients With Subarachnoid Hemorrhage
Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH
Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies
The Planetary Outcomes After Intracranial Haemorrhage Study
Sevoflurane in Subarachnoidal Haemorrhage
Evaluation of Transcutaneous Trigeminal Nerve Stimulation for Prevention of Cerebral Vasospasm After Subarachnoid Haemorrhage